Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.

Industry News

Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer

An agreement between a major European university medical center and a multinational biotechnology company was designed to promote commercialization and further development of a liquid biopsy test for the diagnosis of bladder cancer.  More...
31 Aug 2015

Distribution Agreement to Improve Automated Hemostasis Diagnostics

A new, exclusive-distributer agreement will lead to creating a unique high-performance hemostatis work cell by connecting a laboratory automation system from Thermo Fisher Scientific with a hemostasis testing LAS from Instrumentation Laboratory.  More...
24 Aug 2015
DIASYS DIAGNOSTIC SYSTEMS
KARL HECHT GMBH & CO KG
Dubai Bio Expo-2015

Innovative Microbial Diagnostics Developer Acquired by Biomedical Giant

A biotech company noted for its development of innovative products in the field of molecular microbiology diagnostics has been acquired by one of the world's largest biomedical corporations.  More...
23 Aug 2015

Alere Strengthens Core Strategy Through Two New Transactions

Alere, a leader in rapid diagnostics, continues to strengthen focus on its core business strategy through an agreement to sell BBI Group and an acquisition of US Diagnostics.   More...
10 Aug 2015

Cancer Genetics Expands Access to Proprietary Diagnostics Through Agreement with Harvard Pilgrim

Under the terms of a new agreement between Cancer Genetics and Harvard Pilgrim Healthcare, a health care network covering over one million people throughout Massachusetts, Connecticut, and Maine, CGI will offer its cancer diagnostic services to individuals covered under Harvard Pilgrim plans.  More...
03 Aug 2015

QIAGEN Expands Diagnostics Menu in Partnership with Seegene

In a new collaboration, Seegene will use its proprietary next-generation qPCR technology in developing new multiplex assays for the flagship platform of Qiagen. More...
14 Jul 2015

Next Generation Sequencing Provides Responsiveness for Identifying Resistant Pathogens

According to a new market analysis, next generation sequencing may impact the infectious diseases IVD sector by bypassing some of the downside of PCR-based testing, as NGS can provide more flexibility and responsiveness in identification of new pathogenic strains.  More...
07 Jul 2015


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
 
Copyright © 2000-2015 Globetech Media. All rights reserved.